13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
US6417228B1 · kind B1 · utility
8Cited by
8References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 29, 1999 |
| Grant date | Jul 9, 2002 |
| Priority date | — |
| Expiry date | Oct 29, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
13-Aza analogs of PGF2&agr; and methods of their use in treating glaucoma and ocular hypertension are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.